Filing Flows › Elite Pharmaceuticals (ELTP) › Free cash flow
Elite Pharmaceuticals (ELTP) free cash flow by quarter
Elite Pharmaceuticals' free cash flow was $9.3M in Q1 FY27 (first quarter fiscal 2027), +6% from Q4 FY26. Over the last 5 quarters it ranged from $3.2M (Q4 FY25) to $14.6M (Q1 FY26).
| Quarter | Free cash flow | Q/Q | Y/Y |
|---|---|---|---|
| Q1 FY27 | $9.3M | +6% | -36% |
| Q4 FY26 | $8.7M | +75% | +177% |
| Q2 FY26 | $5.0M | -66% | — |
| Q1 FY26 | $14.6M | +360% | — |
| Q4 FY25 | $3.2M | — | — |
Q1 FY27 at a glance
Elite Pharmaceuticals, Q1 FY27: revenue $32.4M (-20% year over year), operating margin 23.3%, net earnings $5.9M, operating cash flow $10.1M. The chart follows the revenue to costs, profit and cash.
Questions
What is Elite Pharmaceuticals' free cash flow?
Elite Pharmaceuticals' free cash flow was $9.3M in Q1 FY27 (first quarter fiscal 2027), +6% from Q4 FY26.
How has Elite Pharmaceuticals' free cash flow changed?
Over the last 5 quarters it ranged from $3.2M (Q4 FY25) to $14.6M (Q1 FY26).